Prognostic Significance of Hematological Parameters and Coagulation Indices in Assessing COVID-19 Disease Severity: A Single Centre Tertiary Care Covid Hospital Study
International Journal of Pharmaceutical Quality Assurance · 30.03.2026 · 17 (03)
DOI: 10.25258/ijpqa.17.3.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.03.2026. Verfasst von Sneha Barman.
Abstract (Originalsprache)
Introduction
The new coronavirus that triggered the COVID-19 pandemic began to spread quickly over the world in December of 2019. When the epidemic first started, clinical attention was focused on the symptoms and epidemiology in addition to the patients' computed tomography images. A positive nucleotide amplification result would then be used to make the diagnosis.
Aims
The aims to determine the correlation of COVID-19 patients by systematically analyzing the baseline haematological characteristics and laboratory indices. Materials and Method: This is a hospital based; observational cross-sectional study was conducted in the department of pathology Medical College Kolkata in collaboration with the department of chest medicine. The study period was one year. 382 patients were included in this study.
Result
Lymphocyte counts significantly decrease as disease severe (p
Zitieren
APA
Barman, S. (2026). Prognostic Significance of Hematological Parameters and Coagulation Indices in Assessing COVID-19 Disease Severity: A Single Centre Tertiary Care Covid Hospital Study. International Journal of Pharmaceutical Quality Assurance, 17(03). https://doi.org/10.25258/ijpqa.17.3.17
Vancouver
Barman S. Prognostic Significance of Hematological Parameters and Coagulation Indices in Assessing COVID-19 Disease Severity: A Single Centre Tertiary Care Covid Hospital Study. International Journal of Pharmaceutical Quality Assurance. 2026;17(03). doi:10.25258/ijpqa.17.3.17
BibTeX
@article{Barman2026,
author = {Barman, Sneha},
title = {Prognostic Significance of Hematological Parameters and Coagulation Indices in Assessing COVID-19 Disease Severity: A Single Centre Tertiary Care Covid Hospital Study},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {03},
doi = {10.25258/ijpqa.17.3.17}
}
EUVIMED